Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians.
Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians.
复制标题
比较国家医疗学员医师和就读医师的全国样本中阿片类药物使用障碍的治疗观点。
DOI：
10.1016/j.drugalcdep.2020.108217
复制
发表时间：
2020-11-01
影响因子：
4.2
通讯作者：
McGinty EE
中科院分区：
文献类型：
--
作者：
Kennedy-Hendricks A;Barry CL;Stone E;Bachhuber MA;McGinty EE
大多数阿片类药物使用障碍 (OUD) 患者并未接受 FDA 批准的药物美沙酮、丁丙诺啡或纳曲酮的治疗。扩大初级保健中循证 OUD 药物治疗的能力是国家优先事项。没有研究调查初级保健实习医生对这些药物的态度。这项研究调查了全国初级保健实习医生样本，并将他们的观点与初级保健主治医生（即已完成培训的医生）的观点进行了比较。从美国医学会主档案中随机抽取了 1,000 名实习医生和 1,000 名家庭、内科或普通医学专业主治医生。调查于 2019 年 2 月至 8 月邮寄。45% 的合格实习医生和 54% 的合格主治医生做出了回应。卡方检验用于比较各组之间的反应。实习医生比主治医生更有可能同意药物治疗 OUD 比不药物治疗更有效（76% 与 67%，p=0.03）。一半的见习医生 (51%) 表示有兴趣治疗 OUD 患者，而主治医生的这一比例为 20%。实习医生比主治医生更支持放宽 OUD 药物处方限制的政策。相对于主治医生，新兴的初级保健医生可能更愿意与 OUD 患者合作并开药。加强有关 OUD 及其治疗的医疗培训，让临床医生接触 OUD 康复中的个体，并增加对为 OUD 提供药物治疗的临床医生的支持，可能会增强该群体应对阿片类药物危机的能力。
Most people with opioid use disorder (OUD) are not treated with FDA-approved medications methadone, buprenorphine, or naltrexone. Expanding capacity for evidence-based OUD medication in primary care is a national priority. No studies have examined primary care trainee physicians’ attitudes about these medications. This study surveyed a national sample of primary care trainee physicians and compared their views with those of primary care attending physicians (i.e., those who have completed training). Random samples of 1,000 trainee physicians and 1,000 attending physicians specializing in family, internal, or general medicine were selected from the American Medical Association Masterfile. Surveys were mailed February-August 2019. 45% of eligible trainee physicians and 54% of eligible attending physicians responded. Chi-square tests were used to compare responses between the groups. Trainee physicians were more likely than attending physicians to agree that treating OUD with medication is more effective than treatment without medication (76% versus 67%, p=0.03). Half of trainee physicians (51%) expressed interest in treating patients with OUD compared to 20% of attending physicians. Trainee physicians expressed greater support than attending physicians for policies that loosen restrictions on prescribing OUD medications. Relative to attending physicians, the emerging cohort of primary care physicians may be more receptive to working with patients with OUD and prescribing medication. Enhancing medical training on OUD and its treatment, exposing clinicians to individuals in recovery from OUD, and increasing support for clinicians that provide medication treatment for OUD may strengthen this group’s capacity to respond to the opioid crisis.
登录
查看更多内容
DOI：
10.3122/jabfm.2020.01.190230
发表时间：
2020-01-01
影响因子：
2.9
作者：
Peterson, Lars E.;Morgan, Zachary J.;Eden, Aimee R.
通讯作者：
Eden, Aimee R.
影响因子：
6
作者：
Boyd, Susan J.;Fang, Li Juan;Gorelick, David A.
通讯作者：
Gorelick, David A.
影响因子：
5.5
作者：
Haffajee RL;Bohnert ASB;Lagisetty PA
通讯作者：
Lagisetty PA
影响因子：
3.5
作者：
Tesema, Lello;Marshall, Jeffrey;McCormick, Danny
通讯作者：
McCormick, Danny
DOI：
10.1016/j.drugpo.2013.04.001
发表时间：
2013-11-01
期刊：
The International journal on drug policy
影响因子：
--
作者：
Bernstein, Scott E;Bennett, Darcie
通讯作者：
Bennett, Darcie